<DOC>
	<DOCNO>NCT00402402</DOCNO>
	<brief_summary>The purpose study estimate usefulness QuantiFERONÂ®-TB Gold test diagnosis latent tuberculosis infection liver transplant candidate correlate test result risk factor LTBI</brief_summary>
	<brief_title>Comparison Quantiferon-TB Gold Assay With Tuberculin Skin Testing Patients With Chronic Liver Disease</brief_title>
	<detailed_description>Tuberculosis ( TB ) important cause morbidity mortality organ transplant recipient . Although tuberculin skin test ( TST ) recommend screen latent tuberculosis infection ( LTBI ) candidate liver transplantation , performance TST set less optimal , due lack specificity lack sensitivity population relatively immunocompromised . Recently , new test name QuantiFERON-TB Gold ( QFT-G ) approve diagnosis LTBI . QFT-G expect specific TST . However , study define performance QFT-G population patient wait list liver transplantation . We plan estimate usefulness QFT-G test diagnosis LTBI cohort patient end-stage liver disease . We hypothesize QFT-G test correlate well risk LTBI .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>Chronic liver disease wait list wait list liver transplantation Unable provide inform consent Previous history immediate hypersensitivity TST Previous severe local ulceration TST Suspected active TB</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Tuberculin skin test</keyword>
	<keyword>Quantiferon-TB Gold assay</keyword>
	<keyword>Chronic liver disease</keyword>
	<keyword>Liver transplantation</keyword>
	<keyword>Latent tuberculosis infection</keyword>
</DOC>